Literature DB >> 27627645

The Relationship between GRACE Score and Epicardial Fat Thickness in non-STEMI Patients.

Levent Cerit1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27627645      PMCID: PMC5074074          DOI: 10.5935/abc.20160123

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


× No keyword cloud information.
To the Editor, I have read the article entitled "The Relationship between GRACE Score and Epicardial Fat Thickness in non-STEMI Patients" by Gul et al.[1] with great interest. The investigators reported that the GRACE score (GS) showed a positive correlation with end-systolic Epicardial Fat Thickness (EFT) and end-diastolic EFT,[1] and also statistical evaluations demonstrated a better correlation between the GS and end-diastolic EFT compared to end-systolic EFT.[1] Epicardial adipose tissue has the same origin as visceral adipose tissue. Epicardial adipose tissue is known to have endocrine and metabolic activity functions. Secretion of inflammatory cytokines and release of bioactive molecules via EFT may trigger coronary atherosclerosis.[2,3] Evaluation of EFT via echocardiography has several advantages, such as lower cost, easily accessibility, and good reproducibility. However, to evaluate EFT by echocardiography is restricted due to insufficient knowledge in this area.[4] In the present study, EFT was measured in the parasternal long axis view at the end-systole and end-diastole in three cardiac cycles. Echocardiographic evaluation of EFT might not be the optimal alternative for quantification of epicardial tissue. The gold standard in evaluating EFT is magnetic resonance imaging (MRI); the lack of MRI use constitutes a limitation of this study. EFT has a 3-dimensional distribution and two-dimensional echocardiography does not allow viewing all cardiac structures.[5] Although EFT is closely related to coronary artery disease, there are scarce data about the follow-up of EFT in patients with coronary artery disease in the literature. Considering this point of view, further studies are needed to assess EFT follow-up in patients with coronary artery disease.
  5 in total

1.  Epicardial adipose tissue measurement: inexpensive, easy accessible and rapid practical method.

Authors:  Sevket Balta; Sait Demirkol; Ömer Kurt; Hakan Sarlak; Muharrem Akhan
Journal:  Anadolu Kardiyol Derg       Date:  2013-09-10

Review 2.  Echocardiographic epicardial fat: a review of research and clinical applications.

Authors:  Gianluca Iacobellis; Howard J Willens
Journal:  J Am Soc Echocardiogr       Date:  2009-12       Impact factor: 5.251

3.  Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.

Authors:  Jiankang Liu; Caroline S Fox; DeMarc A Hickson; Warren D May; Kristen G Hairston; J Jeffery Carr; Herman A Taylor
Journal:  J Clin Endocrinol Metab       Date:  2010-09-15       Impact factor: 5.958

4.  Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.

Authors:  Adam R Baker; Nancy F da Silva; David W Quinn; Alison L Harte; Domenico Pagano; Robert S Bonser; Sudhesh Kumar; Philip G McTernan
Journal:  Cardiovasc Diabetol       Date:  2006-01-13       Impact factor: 9.951

5.  The Relationship between GRACE Score and Epicardial Fat Thickness in non-STEMI Patients.

Authors:  Ilker Gul; Mustafa Zungur; Ahmet Cagri Aykan; Teyyar Gokdeniz; Ezgi Kalaycioğlu; Turhan Turan; Engin Hatem; Faruk Boyaci
Journal:  Arq Bras Cardiol       Date:  2016-02-16       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.